Transarterial chemoembolization for advanced hepatocellular carcinoma after failure of first-line systemic treatment: a single-center case series
Patients with advanced HCC who face significant treatment challenges could potentially benefit from the addition of TACE to second-line ST.
Authors
- Guowen Yin (ORCID: https://orcid.org/0009-0000-5469-0105)
- Chendong Wang (ORCID: https://orcid.org/0000-0003-2813-6754)
- Bin Leng (ORCID: https://orcid.org/0009-0007-5370-342X)
- Qingyu Xu (ORCID: https://orcid.org/0000-0003-2281-4454)
- Ran You (ORCID: https://orcid.org/0000-0003-3852-5569)
- Lingfeng Diao
- Zeyu Yu (ORCID: https://orcid.org/0009-0003-1100-7953)
Institutions
- Jiangsu Cancer Hospital (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-08-08
- DOI
- https://doi.org/10.1007/s12672-025-03363-9
- Citations
- 1
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.32
Funders
- Jiangsu Cancer Hospital